5-Amino-1MQ 10mg

Description

5-Amino-1MQ is positioned in research contexts as an NNMT (nicotinamide N-methyltransferase) pathway small molecule, not an NMN (nicotinamide mononucleotide) profile, with interpretation generally anchored to broader NNMT inhibition literature.

What it is

5-Amino-1MQ is a small-molecule research profile associated with NNMT (nicotinamide N-methyltransferase) pathway modulation, not NMN (nicotinamide mononucleotide) supplementation.

Mechanism snapshot

• Positioned within NNMT inhibitor-class research for metabolic and methylation-linked pathways, distinct from NMN replacement biology.
• Investigated in target-class studies related to adiposity and metabolic dysfunction biology.
• Assessed through medicinal-chemistry optimization and pathway-level translational frameworks.

Research programs

• NNMT inhibitor class development and optimization studies.
• Metabolic-dysfunction and obesity-pathway preclinical investigations.
• Epigenetic-metabolic interface analyses in target validation projects.

Limitations

• Direct clinical evidence for this specific molecule is limited.
• Class-level findings do not guarantee equivalent compound-level outcomes.
• Translational durability and long-term safety remain unresolved.

Selected references

• Aryl Sulfonamide-Substituted 5-Amino-1-methylquinolinium Derivatives as Potent and Selective Inhibitors of Nicotinamide N-Methyltransferase (NNMT) - PubMed 2021
• Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation - PubMed 2021
• Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunction - PubMed 2024

Ordering

Add this item to your cart, submit your shipping details at checkout, and wait for your order confirmation. Interac e-Transfer instructions are sent after the order request is received.